
Germany’s antitrust watchdog paved the way Wednesday, January 5, for extra scrutiny of Google by designating it a company of “paramount significance,” the first to get that label since regulators got more power to curb abusive practices by big digital companies.
The Bundeskartellamt stated its decision comes after rules were introduced last year that allow it “to intervene earlier and more effectively” to ban companies from using anti-competitive practices. The regulator’s decision, which lasts five years, gives it extended powers to supervise Google for “abuse control.”
The watchdog stated Google has “significant influence” over other companies’ access to its users and advertising customers through search, YouTube, Android, and its online Play Store “and can set rules and conditions for other businesses across markets.”
It’s the latest example of how big tech companies are facing pressure over concerns their dominance stifles competition and hurts consumers. Europe has led the global move to crack down on tech giants, but early efforts drew criticism that investigations took too long, with some stretching on for years — a problem the German rules aim to address.
“This is a very important step, since based on this decision, the Bundeskartellamt can now take action against specific anti-competitive practices by Google,” said the watchdog’s president, Andreas Mundt.
Google is not appealing the decision. It noted the decision doesn’t take a position on the company’s conduct.
“We are confident that we comply with the rules and, to the extent that changes are necessary, we will continue to work constructively with the (Federal Cartel Office) to find solutions that enable people and businesses in Germany to continue to use our products,” Google said in a statement.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas